跳至主要内容
临床试验/NL-OMON42065
NL-OMON42065撤回4 期

Systemic antihistamines in the treatment of attention-deficit/hyperactivity disorder (ADHD): a pilot study. - Antihistamines in the treatment of ADHD.

Medisch Centrum Leeuwarden0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • The study will include children in whom the diagnosis of ADHD has established by a professional and who use methylphenidate and who have comorbid atopic diseases as atopic eczema, asthma, or allergic rhinitis.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Being diagnosed with any chronic disease other than ADHD, including diabetes and epilepsy.
  • - Being treated with other medications on a daily base. Interval treatment with painkillers, bronchodilators, ointments, drops etc. are allowed.
  • - Unable to fulfill study procedures
  • - Not fluent in Dutch language
  • - Sufficiently treated and no improvement expected, as judged by the parents.

研究者

发起方
Medisch Centrum Leeuwarden

相似试验

Systemic antihistamines in the treatment of... | 临床试验